Title : Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.

Pub. Date : 2021

PMID : 34868078






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the treatment of vitiligo, JAK inhibitors, including ruxolitinib, baricitinib, and tofacitinib, are effective, supporting the implication of the IFN-gamma-chemokine signaling axis in the pathogenesis of vitiligo. tofacitinib interferon gamma Homo sapiens